Come up with a name for your new list and we'll add to it:
Glythera raised a round of funding on July 09, 2013. Investors include
Finance for Business North East Fund.
Glythera specializes in the development of next generation biotherapeutics, through the application of its advanced proprietary linker and stable glycan technologies: PermaLink and PermaCarb. Its link…